Details for Patent: 8,889,722
✉ Email this page to a colleague
Which drugs does patent 8,889,722 protect, and when does it expire?
Patent 8,889,722 protects MULPLETA and is included in one NDA.
This patent has twenty-six patent family members in twenty countries.
Summary for Patent: 8,889,722
| Title: | Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity, and intermediate therefor |
| Abstract: | An optically active 4-phenylthiazole derivative having a thrombopoietin receptor agonist activity and a pharmaceutical composition containing the present compound as an active ingredient are created, and a platelet production regulating agent which can be orally administered is provided. Disclosed is a pharmaceutical composition containing, as an active ingredient, an optically active compound represented by the formula: ##STR00001## wherein, R.sup.1 is a halogen atom or C1-C3 alkyloxy; R.sup.2 is C1-C8 alkyl; R.sup.3 is C1-C8 alkyl; R.sup.4 and R.sup.5 are each independently a fluorine atom or chlorine atom; R.sup.6 is C1-C3 alkyl or C1-C3 alkyloxy; * indicates that a carbon atom marked with an asterisk is an asymmetric carbon, a pharmaceutically acceptable salt thereof, or a solvate thereof. |
| Inventor(s): | Takayama; Masami (Osaka, JP), Kurose; Noriyuki (Osaka, JP) |
| Assignee: | Shionogi & Co., Ltd. (Osaka-Shi, Osaka, JP) |
| Application Number: | 13/766,752 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,889,722
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,889,722
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2007-198590 | Jul 31, 2007 |
International Family Members for US Patent 8,889,722
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2184279 | ⤷ Sign Up | 300998 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2184279 | ⤷ Sign Up | 122019000065 | Germany | ⤷ Sign Up |
| European Patent Office | 2184279 | ⤷ Sign Up | 2019C/534 | Belgium | ⤷ Sign Up |
| European Patent Office | 2184279 | ⤷ Sign Up | CA 2019 00038 | Denmark | ⤷ Sign Up |
| European Patent Office | 2184279 | ⤷ Sign Up | 132019000000090 | Italy | ⤷ Sign Up |
| European Patent Office | 2184279 | ⤷ Sign Up | 1990035-6 | Sweden | ⤷ Sign Up |
| European Patent Office | 2184279 | ⤷ Sign Up | CR 2019 00038 | Denmark | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
